Critical Care Management of Toxicities Associated With Targeted Agents and Immunotherapies for Cancer
Conclusions:
The complexity of toxicities associated with modern targeted and immunotherapeutic agents for cancer require a multidisciplinary approach among ICU staff, oncologists, and organ specialists and adoption of standardized treatment protocols to ensure the best possible patient outcomes.
Source: Critical Care Medicine - Category: Emergency Medicine Tags: Feature Articles Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Corticosteroid Therapy | Emergency Medicine | Immunotherapy | Neurology | Study | Toxicology